Phibro Animal Health reported $3.06M in Interest Expense on Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Ani Pharmaceuticals ANIP:US $ 2.5M 34K
Aphria Inc APH:CN C$ 10.45M 3.97M
Aurora Cannabis Inc ACB:CN 15.34M 544K
Bristol Myers Squibb BMY:US $ 328M 2M
Depomed DEPO:US $ 2.5M 0.11M
Eli Lilly And LLY:US $ 83.6M 3.3M
Endo International Ordinary Shares ENDP:US $ 142.99M 1.35M
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Henry Schein HSIC:US $ 6.55M 0.17M
Idexx Laboratories IDXX:US $ 7.13M 0.48M
JAZZ PHA JAZZ:US $ 93.47M 23.65M
Knight Therapeutics Inc GUD:CN C$ 959K 291K
Lannett LCI:US $ 14.22M 1.01M
Nektar Therapeutics NKTR:US $ 12.8M 0.29M
Pacira Pharmaceuticals PCRX:US $ 7.33M 0.31M
Patterson Companies PDCO:US $ 5.52M 0.33M
Phibro Animal Health PAHC:US $ 3.06M 0.03M
Prestige Brands PBH:US $ 16.31M 1.24M
Supernus Pharmaceuticals SUPN:US $ 5.92M 1.43M
Teva Pharmaceutical Industries TEVA:US $ 232M 8M
Zoetis ZTS:US $ 56M 1M